The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Meggitt surges on merger mumbles, Carney chat hits housebuilders

Tue, 14th Jul 2015 14:29

(ShareCast News) - London markets edged lower on Tuesday, as losses from housebuilders, engineers and financials eclipsed gains made by industrial metals.As of 14:00 BST, the FTSE 100 was trading 0.2% lower at 6,727.Shares in defence and aerospace engineer Meggitt rose following a report in the Financial Times that a merger with Cobham might be on the cards. Atif Latif, director of trading at Guardian Stockbrokers, said he sees the rationale of a tie-up between the two as a defence play.AstraZeneca gained as its Iressa drug, which is used in the treatment of metastatic non-small cell lung cancer (NSCLC), was approved by the US Food and Drug Administration. Iressa is already approved in 91 countries for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor mutation-positive NSCLC, which is the most common type of lung cancer.Sky surged as analysts at Deutsche Bank upgraded their rating on the stock from 'hold' to 'buy' and raised estimates for 2017 by 20% more than the wider consensus. In a note to clients, Deutsche Bank said the European satellite TV giant was the best positioned in Europe to capitalise on growth areas related to online video.Meanwhile ITV was under the cosh in early trading after Deutsche Bank downgraded the stock to 'sell' from 'hold'. "We find the upside case of retransmission fees, Liberty takeout and cash returns/dividends unconvincing," said the bank.This seemed to outweigh a note from Morgan Stanley on the media sector that picked out ITV as one of its favoured stocks, while also downgrading Pearson to 'equal weight' from 'overweight'. Pearson's shares fell around 1.8% by mid afternoon.Shares in housebuilders such as Taylor Wimpey, Barratt Developments and Persimmon were all knocked lower as Mark Carney told the Treasury Select Committee that the bank rate may be headed higher a little bit sooner than markets anticipated.RisersSky (SKY) 1,115.00p +3.43%Meggitt (MGGT) 480.80p +2.19%Morrison (Wm) Supermarkets (MRW) 180.10p +1.18%Sainsbury (J) (SBRY) 265.40p +0.87%Reed Elsevier (REL) 1,094.00p +0.83%Glencore (GLEN) 252.40p +0.80%Unilever (ULVR) 2,903.00p +0.76%Direct Line Insurance Group (DLG) 348.30p +0.66%Tesco (TSCO) 213.85p +0.64%British American Tobacco (BATS) 3,639.00p +0.61%FallersTaylor Wimpey (TW.) 185.40p -3.39%Persimmon (PSN) 1,958.00p -2.78%Barratt Developments (BDEV) 624.00p -2.73%GKN (GKN) 317.10p -2.28%TUI AG Reg Shs (DI) (TUI) 1,066.00p -1.93%Weir Group (WEIR) 1,595.00p -1.73%Aberdeen Asset Management (ADN) 402.50p -1.61%Johnson Matthey (JMAT) 3,005.00p -1.48%Hammerson (HMSO) 652.50p -1.44%Marks & Spencer Group (MKS) 540.00p -1.37%
More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.